PMDA
- Application: Zykadia
- Local brand name: Zykadia
- Status: approved
Zykadia (ceritinib) regulatory status in Japan.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA has authorised it.
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.